ERBB2 and neoplasm: Few patients (14, 10.2%) were HER2-positive at the time of primary diagnosis; 4 patients (2.9%) gained (3 patients) or lost (1 patient) HER2-positive tumor staining (Table 2), although this failed to achieve statistical significance for a change in HER2 receptor scores (P = 0.074).